Publications by authors named "M Kizilgul"
Purpose: The factors predicting the long-term response to cabergoline are not well known, particularly in more invasive prolactinomas. This study aimed to evaluate the rate of good response (GR) (normoprolactinemia and ≥ 50% tumor shrinkage) at the one-year follow-up and to identify predictors of GR in patients with large invasive prolactinomas.
Methods: This retrospective single-center study included 38 patients (32 males, 6 females; mean age 41.
Patients with primary hyperparathyroidism (PHPT) are predisposed to hypomagnesemia as well as hypophosphatemia. In the current literature, scarce data was available on the clinical significance of hypomagnesemia in PHPT. The present study aimed to investigate the prevalence of hypomagnesemia and its association with complications of PHPT in a large nationwide cohort.
View Article and Find Full Text PDFArticle Synopsis
- - The study investigates the ECG characteristics of 103 acromegaly patients to assess the risk of cardiovascular complications and life expectancy, highlighting the significance of the Tp-e interval and its ratios as indicators of ventricular arrhythmia risk.
- - Results show that patients with both baseline and current ECGs experienced a decrease in heart rate, QRS duration, and several arrhythmia parameters, which were similarly affected regardless of whether the patients were in active or remission stages of the disease.
- - The conclusion emphasizes that treatment leads to improved ventricular arrhythmia parameters in acromegaly patients, which correlates with a significant reduction in IGF-1 levels, even in those with ongoing active disease.
Background: In recent years, there has been increasing data showing that the risk of acute pancreatitis (AP) is increased in patients using methimazole (MMI). The aim of this population-based study was to investigate the association between drugs used in the treatment of hyperthyroidism (MMI, PTU, propranolol) and the diagnosis of AP.
Material And Methods: The database consisted of more than 85 million citizen records between January 1, 2017 and December 31, 2022.
Background: The ongoing debate regarding the need for screening Cushing's syndrome (CS) in patients with obesity continues. The objectives of this study were to establish the prevalence of CS in the population with obesity and assess how metabolic health status influences cortisol levels following the 1 mg dexamethasone suppression test (DST).
Methods: This retrospective study included 1008 patients with obesity who underwent screening with the 1 mg DST for CS.